227 related articles for article (PubMed ID: 10458621)
1. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.
Mocroft A; Sabin CA; Youle M; Madge S; Tyrer M; Devereux H; Deayton J; Dykhoff A; Lipman MC; Phillips AN; Johnson MA
J Acquir Immune Defic Syndr; 1999 Aug; 21(5):401-7. PubMed ID: 10458621
[TBL] [Abstract][Full Text] [Related]
2. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
3. The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Mocroft A; Youle M; Phillips AN; Halai R; Easterbrook P; Johnson MA; Gazzard B
Arch Intern Med; 1998 Mar; 158(5):491-7. PubMed ID: 9508227
[TBL] [Abstract][Full Text] [Related]
4. Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort.
Dore GJ; Hoy JF; Mallal SA; Li Y; Mijch AM; French MA; Cooper DA; Kaldor JM
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Sep; 16(1):39-43. PubMed ID: 9377123
[TBL] [Abstract][Full Text] [Related]
5. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
[TBL] [Abstract][Full Text] [Related]
6. The changing spectrum of AIDS index diseases in Canada.
Montaner JS; Le T; Hogg R; Ricketts M; Sutherland D; Strathdee SA; O'Shaughnessy M; Schechter MT
AIDS; 1994 May; 8(5):693-6. PubMed ID: 8060550
[TBL] [Abstract][Full Text] [Related]
7. Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance.
Schwarcz L; Chen MJ; Vittinghoff E; Hsu L; Schwarcz S
AIDS; 2013 Feb; 27(4):597-605. PubMed ID: 23079812
[TBL] [Abstract][Full Text] [Related]
8. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
[TBL] [Abstract][Full Text] [Related]
9. Incidence of clinical AIDS conditions in a cohort of homosexual men with CD4+ cell counts < 100/mm3. Multicenter AIDS Cohort Study.
Bacellar H; Muñoz A; Hoover DR; Phair JP; Besley DR; Kingsley LA; Vermund SH
J Infect Dis; 1994 Nov; 170(5):1284-7. PubMed ID: 7963728
[TBL] [Abstract][Full Text] [Related]
10. AIDS-defining illnesses among patients with HIV in Singapore, 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS).
Bellamy R; Sangeetha S; Paton NI
BMC Infect Dis; 2004 Nov; 4():47. PubMed ID: 15538953
[TBL] [Abstract][Full Text] [Related]
11. AIDS defining diseases in the UK: the impact of PCP prophylaxis and twelve years of change.
Porter K; Fairley CK; Wall PG; Evans BG; Goldberg DJ; Weerasuriya M; Noone A
Int J STD AIDS; 1996 Jul; 7(4):252-7. PubMed ID: 8876355
[TBL] [Abstract][Full Text] [Related]
12. Incidence and spectrum of AIDS-defining illnesses among persons treated with antiretroviral drugs.
Michaels SH; Clark R; Kissinger P
Clin Infect Dis; 1999 Aug; 29(2):468-9. PubMed ID: 10476778
[No Abstract] [Full Text] [Related]
13. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
Moore RD; Chaisson RE
Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
[TBL] [Abstract][Full Text] [Related]
14. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.
Palella FJ; Delaney KM; Moorman AC; Loveless MO; Fuhrer J; Satten GA; Aschman DJ; Holmberg SD
N Engl J Med; 1998 Mar; 338(13):853-60. PubMed ID: 9516219
[TBL] [Abstract][Full Text] [Related]
15. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
; Mocroft A; Sterne JA; Egger M; May M; Grabar S; Furrer H; Sabin C; Fatkenheuer G; Justice A; Reiss P; d'Arminio Monforte A; Gill J; Hogg R; Bonnet F; Kitahata M; Staszewski S; Casabona J; Harris R; Saag M
Clin Infect Dis; 2009 Apr; 48(8):1138-51. PubMed ID: 19275498
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis.
Detels R; Tarwater P; Phair JP; Margolick J; Riddler SA; Muñoz A;
AIDS; 2001 Feb; 15(3):347-55. PubMed ID: 11273215
[TBL] [Abstract][Full Text] [Related]
17. Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS.
Chan IS; Neaton JD; Saravolatz LD; Crane LR; Osterberger J
AIDS; 1995 Oct; 9(10):1145-51. PubMed ID: 8519450
[TBL] [Abstract][Full Text] [Related]
18. Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.
Grabar S; Lanoy E; Allavena C; Mary-Krause M; Bentata M; Fischer P; Mahamat A; Rabaud C; Costagliola D;
HIV Med; 2008 Apr; 9(4):246-56. PubMed ID: 18366449
[TBL] [Abstract][Full Text] [Related]
19. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996.
Pezzotti P; Serraino D; Rezza G; Dal Maso L; Vaccher E; Lepri AC; Franceschi S
Int J Epidemiol; 1999 Oct; 28(5):975-81. PubMed ID: 10597999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
